Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Salomon Tendler"'
Autor:
Luca Marzano, Adam S. Darwich, Asaf Dan, Salomon Tendler, Rolf Lewensohn, Luigi De Petris, Jayanth Raghothama, Sebastiaan Meijer
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 8, Pp n/a-n/a (2024)
Abstract The potential of real‐world data to inform clinical trial design and supplement control arms has gained much interest in recent years. The most common approach relies on reproducing control arm outcomes by matching real‐world patient coh
Externí odkaz:
https://doaj.org/article/1b179c89e7a94476879044a3a0369bfe
Autor:
Luca Marzano, Adam S. Darwich, Salomon Tendler, Asaf Dan, Rolf Lewensohn, Luigi De Petris, Jayanth Raghothama, Sebastiaan Meijer
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 10, Pp 2437-2447 (2022)
Abstract In recent studies, small cell lung cancer (SCLC) treatment guidelines based on Veterans’ Administration Lung Study Group limited/extensive disease staging and resulted in broad and inseparable prognostic subgroups. Evidence suggests that t
Externí odkaz:
https://doaj.org/article/3b96a4fe9f5b47afb4e72d9bdf159dff
Autor:
Salomon Tendler, Lena Kanter, Rolf Lewensohn, Cristian Ortiz-Villalón, Kristina Viktorsson, Luigi De Petris
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240973 (2020)
ObjectivesThe aim was to analyse the tumor expression of Notch1, Hes1, Ascl1, and DLL3 in Small-Cell Lung Cancer (SCLC) and each such biomarker's potential association with clinical characteristics and prognosis after platinum-doublet chemotherapy (P
Externí odkaz:
https://doaj.org/article/09a6bb0f38b54c8a9ddae41ad7cc1124
Autor:
Salomon Tendler, Charles M. Rudin
Publikováno v:
Journal of Clinical Oncology. 41:2877-2880
Autor:
Luca Marzano, Sebastiaan Meijer, Asaf Dan, Salomon Tendler, Luigi De Petris, Rolf Lewensohn, Jayanth Raghothama, Adam S. Darwich
Publikováno v:
Caring is Sharing – Exploiting the Value in Data for Health and Innovation ISBN: 9781643683881
Process mining is a relatively new method that connects data science and process modelling. In the past years a series of applications with health care production data have been presented in process discovery, conformance check and system enhancement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4ecbeff5f2a80b3ae4dfb718a88078
https://doi.org/10.3233/shti230056
https://doi.org/10.3233/shti230056
Autor:
Jason S. Lewis, Charles M. Rudin, John T. Poirier, Nagavarakishore Pillarsetty, Triparna Sen, William D. Travis, Alessandra Piersigilli, Avelyn Mae Delos Reyes, Joshua A. Korsen, Komal Mandleywala, Zachary V. Samuels, Sai Kiran Sharma, Lukas M. Carter, Salomon Tendler, Kathryn M. Tully
Supplementary Figure from Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d287ee932905c9f73acd65d57e15e2
https://doi.org/10.1158/1078-0432.22483574
https://doi.org/10.1158/1078-0432.22483574
Autor:
Jason S. Lewis, Charles M. Rudin, John T. Poirier, Nagavarakishore Pillarsetty, Triparna Sen, William D. Travis, Alessandra Piersigilli, Avelyn Mae Delos Reyes, Joshua A. Korsen, Komal Mandleywala, Zachary V. Samuels, Sai Kiran Sharma, Lukas M. Carter, Salomon Tendler, Kathryn M. Tully
Supplementary Data from Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1de601a14384c3143c8705e31f669435
https://doi.org/10.1158/1078-0432.22483580.v1
https://doi.org/10.1158/1078-0432.22483580.v1
Autor:
Jason S. Lewis, Charles M. Rudin, John T. Poirier, Nagavarakishore Pillarsetty, Triparna Sen, William D. Travis, Alessandra Piersigilli, Avelyn Mae Delos Reyes, Joshua A. Korsen, Komal Mandleywala, Zachary V. Samuels, Sai Kiran Sharma, Lukas M. Carter, Salomon Tendler, Kathryn M. Tully
Purpose:Small cell lung cancer (SCLC) is an exceptionally lethal form of lung cancer with limited treatment options. Delta-like ligand 3 (DLL3) is an attractive therapeutic target as surface expression is almost exclusive to tumor cells.Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f434032382cffa213eacf1d20935fda
https://doi.org/10.1158/1078-0432.c.6531161
https://doi.org/10.1158/1078-0432.c.6531161
Autor:
Kathryn M. Tully, Salomon Tendler, Lukas M. Carter, Sai Kiran Sharma, Zachary V. Samuels, Komal Mandleywala, Joshua A. Korsen, Avelyn Mae Delos Reyes, Alessandra Piersigilli, William D. Travis, Triparna Sen, Nagavarakishore Pillarsetty, John T. Poirier, Charles M. Rudin, Jason S. Lewis
Publikováno v:
Clin Cancer Res
Purpose:Small cell lung cancer (SCLC) is an exceptionally lethal form of lung cancer with limited treatment options. Delta-like ligand 3 (DLL3) is an attractive therapeutic target as surface expression is almost exclusive to tumor cells.Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b3a5deca4dbc7c3693c7e8d626b7ffa
https://europepmc.org/articles/PMC8976830/
https://europepmc.org/articles/PMC8976830/
Autor:
Salomon Tendler, Mats Lambe, Luigi De Petris, Marit Holmqvist, Gunnar Wagenius, Rolf Lewensohn
Publikováno v:
Lung Cancer. 139:111-117
Objectives To examine if educational status is associated with outcome in patients with Small Cell Lung Cancer (SCLC). The study also investigated differences in patterns of management (lead times and treatment intensity) between educational levels.